Mibelle AG   Report issue

For profit
Founded: Buchs Switzerland (1961)
Status: No NME R&D (1961)

Organization Overview

First Clinical Trial
2018
NCT03673930
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Mibelle AG | Mibelle Group Biochemistry

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 5